KRSNAA NSE filing

Krsnaa Diagnostics Publishes Audited Financial Results for FY26 Q4

The RealCase readLow impact Neutral

Krsnaa Diagnostics Limited published its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Advertisements appeared on May 27, 2026, in Financial Express and Loksatta. Results will be available on the company's investor website.

Why it matters

This is a standard disclosure of financial results publication. The actual financial performance details are not included in this announcement, limiting its immediate impact.

The market read

The announcement is a routine disclosure of financial results publication and does not contain any specific performance metrics or forward-looking statements that would indicate a positive or negative sentiment.

Krsnaa Diagnostics Limited has published newspaper advertisements regarding its audited financial results for the quarter and the full financial year ended March 31, 2026. These results include both standalone and consolidated financial statements.

The advertisements were published on May 27, 2026, in two prominent newspapers: the Financial Express (English) and Loksatta (Marathi).

The company will also host these financial results on its official website, www.krsnaadiagnostics.com/investors, for public access. This disclosure is in compliance with Regulation 47 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Filing to action

What to do with a filing like this

Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.

View original filing